Orfei P, Pinto G, Properzi E, Piccardo A, Cerroni A, Prosperi M, Cozzi F
Istituto di Anestesiologia e Rianimazione, Università degli Studi di Roma, La Sapienza.
Minerva Anestesiol. 1996 Apr;62(4):143-50.
From January 1992 to October 1994, 74 central venous catheters were inserted, in the University Hospital of Rome: Polyclinic Umberto I - "La Sapienza", in 62 paediatric patients (15.17 +/- 1.64 years old), admitted to the paediatric surgery division. The authors used a large amount of CVC: totally implanted devices (34 Groshong, 7 Broviac, 2 Hickman, 3 Port) and percutaneous catheters (28 Arrow). The choice of the infusional devices has been influenced by the length of the treatment, the primitive disease, the age and the size of the patient. The authors used totally implanted devices in paediatric patients undergoing chemotherapeutic and nutritional therapies. External central venous access devices were used in patients undergoing central catheterization lasting less than two months. The subclavian vein has been used as venous access in patients weighing > 5 kg, the internal jugular vein in < 5, kg patients. This work reports the early (PNX, hematomas, arterial access) and the long term complications (infections, accidental unthreading, occlusions and dislocations). We can say that the medium and long last term CVC is well tolerated and accepted in paediatric patients too, for antineoplastic, nutritional and infusion therapies.
1992年1月至1994年10月,罗马大学医院:翁贝托一世综合医院 - “拉齐奥大学”为62名儿科患者(年龄15.17 +/- 1.64岁)插入了74根中心静脉导管,这些患者均入住小儿外科。作者使用了大量中心静脉导管:完全植入式装置(34根Groshong导管、7根Broviac导管、2根Hickman导管、3根Port导管)和经皮导管(28根Arrow导管)。输液装置的选择受到治疗时长、原发病、患者年龄和体型的影响。作者在接受化疗和营养治疗的儿科患者中使用完全植入式装置。在接受中心静脉置管时间少于两个月的患者中使用外部中心静脉通路装置。体重>5 kg的患者采用锁骨下静脉作为静脉通路,体重<5 kg的患者采用颈内静脉。本研究报告了早期并发症(气胸、血肿、动脉穿刺)和长期并发症(感染、意外脱管、堵塞和移位)。我们可以说,中长期中心静脉导管在儿科患者中也能很好地耐受和接受,可用于抗肿瘤、营养和输液治疗。